Acute liver failure laboratory findings: Difference between revisions
Line 4: | Line 4: | ||
Overview | |||
All patients with clinical or laboratory evidence of moderate to severe acute hepatitis should have an immediate measurement of prothrombin time and careful evaluation of mental status. If the prothrombin time is prolonged | |||
Acute liver failure can present with nonspecific symptoms and it occurs in healthy individuals without a previous history of liver disease. So, the initial labs in the acute liver failure are planned to evaluate both the etiology and the severity of the disease. All patients with clinical or laboratory evidence of moderate to severe acute hepatitis should have an immediate measurement of prothrombin time and careful evaluation of mental status. If the prothrombin time is prolonged (INR ≥1.5) and there is any evidence of altered [[sensorium]], the diagnosis of acute liver failure should be strongly suspected and hospital admission is mandatory. | |||
==Laboratory Findings== | ==Laboratory Findings== | ||
Line 19: | Line 20: | ||
* Increased | * Increased | ||
| | | | ||
* Prolonged prothrombin time, resulting in an INR ≥1.5; it shows coagulopathy which is a part of acute liver failure criteria. | * Prolonged [[prothrombin time]], resulting in an INR ≥1.5; it shows [[coagulopathy]] which is a part of acute liver failure criteria. | ||
|- | |- | ||
| align="center" style="background:#DCDCDC;" + | | | align="center" style="background:#DCDCDC;" + | | ||
Line 26: | Line 27: | ||
* Low | * Low | ||
| | | | ||
* Anemia may be present | * [[Anemia]] may be present | ||
|- | |- | ||
| colspan="1" rowspan="1" align="center" style="background:#DCDCDC;" + | | | colspan="1" rowspan="1" align="center" style="background:#DCDCDC;" + | | ||
Line 33: | Line 34: | ||
* Elevated | * Elevated | ||
| | | | ||
* Liver enzymes are elevated in acute liver failure. The decrease in liver enzymes may indicate recovery or worsening of liver failure and an indication | * [[Liver enzymes]] are elevated in acute liver failure. The decrease in liver enzymes may indicate recovery or worsening of liver failure and an indication of hepatic mass loss. | ||
|- | |- | ||
| | | | ||
Line 40: | Line 41: | ||
* Elevated | * Elevated | ||
| | | | ||
* Bilirubin and PT/INR | * [[Bilirubin]] and [[INR|PT/INR]] will continue to rise in liver failure but if a patient is improving, bilirubin and PT/INT will also improve. | ||
|- | |- | ||
| | | | ||
Line 47: | Line 48: | ||
* Low | * Low | ||
| | | | ||
* Albumin indicates the synthetic function of the liver. | * [[Albumin]] indicates the synthetic function of the liver. | ||
|- | |- | ||
| colspan="1" rowspan="1" align="center" style="background:#DCDCDC;" + | | | colspan="1" rowspan="1" align="center" style="background:#DCDCDC;" + | | ||
Line 54: | Line 55: | ||
* Low | * Low | ||
| | | | ||
* Decrease hepatic glycogenolysis and gluconeogenesis | * Decrease hepatic [[glycogenolysis]] and [[gluconeogenesis]] | ||
|- | |- | ||
| | | | ||
Line 61: | Line 62: | ||
* Elevated | * Elevated | ||
| | | | ||
* Decrease clearance in hepatorenal syndrome | * Decrease clearance in [[hepatorenal syndrome]] | ||
|- | |- | ||
| align="center" style="background:#DCDCDC;" + | | | align="center" style="background:#DCDCDC;" + | | ||
Line 67: | Line 68: | ||
| | | | ||
| | | | ||
* Detectable in acetaminophen poisioning | * Detectable in [[acetaminophen]] poisioning | ||
|- | |- | ||
| align="center" style="background:#DCDCDC;" + | | | align="center" style="background:#DCDCDC;" + | | ||
Line 74: | Line 75: | ||
* Dectectable in viral hepatitis | * Dectectable in viral hepatitis | ||
| | | | ||
* Viral serology and PCR can detect the viral agent | * Viral serology and [[PCR]] can detect the viral agent | ||
|- | |- | ||
| | | | ||
Line 81: | Line 82: | ||
* Detectable in auto immune hepatitis. | * Detectable in auto immune hepatitis. | ||
| | | | ||
* Antibody screen can detect antibodies associated with autoimmune hepatitis such as anti-smooth muscle antibody or ANA. | * Antibody screen can detect antibodies associated with [[autoimmune hepatitis]] such as [[anti-smooth muscle antibody]] or [[ANA]]. | ||
|- | |- | ||
| | | | ||
Line 87: | Line 88: | ||
| | | | ||
| | | | ||
* Elevated in wilson's disease | * Elevated in [[Wilson's disease|wilson's]] disease | ||
|- | |- | ||
| | | | ||
Line 94: | Line 95: | ||
* Elevated | * Elevated | ||
| | | | ||
* Blood lactate is elevated due to decrease hepatic clearance and ischemia to hepatic tissue | * Blood [[lactate]] is elevated due to decrease [[hepatic]] clearance and [[ischemia]] to hepatic tissue | ||
|- | |- | ||
| | | | ||
Line 101: | Line 102: | ||
* Elevated | * Elevated | ||
| | | | ||
* Decrease ammonia clearance | * Decrease [[ammonia]] clearance | ||
|} | |} | ||
Revision as of 19:21, 16 November 2017
Acute liver failure Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
Acute liver failure laboratory findings On the Web |
American Roentgen Ray Society Images of Acute liver failure laboratory findings |
Risk calculators and risk factors for Acute liver failure laboratory findings |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief:
Overview
Acute liver failure can present with nonspecific symptoms and it occurs in healthy individuals without a previous history of liver disease. So, the initial labs in the acute liver failure are planned to evaluate both the etiology and the severity of the disease. All patients with clinical or laboratory evidence of moderate to severe acute hepatitis should have an immediate measurement of prothrombin time and careful evaluation of mental status. If the prothrombin time is prolonged (INR ≥1.5) and there is any evidence of altered sensorium, the diagnosis of acute liver failure should be strongly suspected and hospital admission is mandatory.
Laboratory Findings
- Acute liver failure can present with nonspecific symptoms and it occurs in healthy individuals without a previous history of liver disease. So, the initial labs in the acute liver failure are planned to evaluate both the etiology and the severity of the disease.[1]
LAB | values in Acute liver failure | Comments |
---|---|---|
|
| |
|
| |
|
| |
|
|
|
|
| |
|
| |
|
| |
|
| |
|
|
|
|
|
|
|
| |
|
||
|
|
References
- ↑ Polson J, Lee WM (2005). "AASLD position paper: the management of acute liver failure". Hepatology. 41 (5): 1179–97. doi:10.1002/hep.20703. PMID 15841455.